Middlesbrough hospital consultants charged 108% more for parking
Some members of staff on lower salaries would see a decrease in charges but consultants would pay a tariff for a dedicated car park for them, said the UHT.The BMA has said charges for consultants at the hospital have gone up by 108%, with some doctors on specific shift patterns seeing increases in excess of 125%.The price changes will bring the South Tees hospitals in line with the policy of the North Tees and Hartlepool NHS Trust, which has had varied prices for staff over the last 10 years.
'Lack of understanding'
Dr Andy Thornley, representing the BMA, said: "Charging staff who are just trying to come to work to care for patients at the hospital to make financial gains for a struggling trust is wrong. "Worse still is the unfair charges that patients and their visitors are being forced to pay, with no choice in order to access the hospital."This is just the latest in what can only be described as chaotic implementation of new parking measures at the hospital, impacting not only consultants but also resident doctors who are still unsure what the new charges will mean for them."We want assurances that staff who are members of the parking scheme will not be fined additional charges for simply coming to work to care for patients."A UNISON spokesperson reinforced this message, stating that imposing higher parking charges on NHS staff and patients "shows a shocking lack of understanding" of the financial struggle many are facing.The trust has said it is the first increase in two years and that any surplus funds will be diverted into patient care.A spokesperson said: "We understand the price rise is not welcome news, but we have kept the increase as low as possible."We would like to reassure all our patients and visitors that the income from car parking is used to maintain our car parks including the costs of repairs and maintenance, lighting, gritting and security, all of which helps us to retain our 'Park Mark' Safer Parking Scheme accreditation."This coming year will see us invest £1.8m in improvements to our car parking."
Follow BBC Tees on X, Facebook, Nextdoor and Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Guardian
19 minutes ago
- South Wales Guardian
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
Times
35 minutes ago
- Times
I was a Gen Z screen addict. Then I took drastic action
A lot can happen in seven hours. You could fly from London to Dubai, get through a full school day or enjoy a luxurious night's sleep. Me? I used to spend seven hours a day staring at my phone screen. Now I average less than one. I'm 22 and I've spent an alarming percentage of my life glued to my phone. It was everything — my entertainment, my social lifeline, my procrastination tool, my 3am therapist. I'm far from alone. Data shows that Generation Z's daily screen time is on average more than nine hours a day, which is more than any other generation. That's about 136 days a year spent staring at a screen. Meanwhile, the NHS reports a steep rise in mental health disorders among young people, which tracks closely with the explosion in digital device use.
Leader Live
an hour ago
- Leader Live
Pharmacies warn of unsustainable demand for weight loss medication
Many more patients are interested in using weight loss medication than are actually suitable for treatment, according to the National Pharmacy Association (NPA), which represents more than 6,000 independent community pharmacies. Some 21% of people who were interviewed in a NPA-commissioned poll agreed they had attempted to access weight loss treatments in the last year, either online or in person at a pharmacy, rising to 35% of 16 to 34-year-olds. This is compared to only 7% of those over 55. There were also 41% who agreed they would opt for weight loss treatments on the NHS if they were made available to them. This figure rose to 64% among 25 to 34-year-olds, despite many of these patients being unlikely to be clinically eligible. The NPA says the poll, in which 2,002 people were interviewed, reflects an increasing demand for private and NHS weight loss services. NPA chairman Olivier Picard said: 'Weight loss jabs are one of the biggest drug innovations this century, but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it. 'It's clear from this polling that many more people are interested in getting weight loss jabs than would actually be suitable for treatment. 'We want to make sure supplies are carefully managed so that those in most clinical need can benefit from weight loss medication.' Spiralling demand, fuelled partly by social media, could see people being tempted to resort to unregulated online suppliers instead of regulated pharmacies staffed by medical professionals, they fear. Online suppliers may not be offering weight loss jabs alongside a structured programme aimed at helping them change their behaviour. Wegovy and Mounjaro are among a number of drugs that are recommended to help tackle obesity on the NHS. Mounjaro and Wegovy are licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for use in patients with a BMI of over 30 or between 27 and 30 but with a weight-related co-morbidity. This occurs when an individual who has obesity develops another medical condition due to their weight. The NHS currently rolls out Mounjaro to patients with a BMI of over 40 and at least four co-morbidities, the NPA says. The NPA is calling for new regulations to protect patients buying weight loss medication online, so there is a full two-way consultation and all relevant historical medical records are reviewed before the treatment is prescribed. They are waiting for more details about the role pharmacies could play in the rollout of the NHS weight management programme. At least 85% of weight loss medication prescriptions were made by pharmacies in April this year, the NPA estimates. Mr Picard said: 'Pharmacists are experts in medication and many have extensive experience delivering weight loss injections as part of a package of care, including lifestyle advice. 'Pharmacies are well placed to help roll this treatment out on the NHS, and help people make the best use of these powerful medicines.'
